Free Research Reports on BLRX, DCTH, WNR and XONE Issued by the Bedford Report

NEW YORK, NY -- (Marketwired) -- 04/08/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Bioline RX Ltd. (NASDAQ: BLRX) shares have declined approximately 55 percent in the past month. The company recently announced that it has decided to end the Phase II/III CLARITY trial of BL-1020, its treatment for schizophrenia, as it was unlikely to meet its pre-specified primary efficacy endpoint.

Find out more about Bioline RX including full access to the free equity report at: www.BedfordReport.com/BLRX

Delcath Systems, Inc. (NASDAQ: DCTH) shares declined 5.76 percent on volume of 4.30 million shares traded to close at $1.80 a share Wednesday. The company reported an operating loss of $53.9 million for the full year 2012, compared to an operating loss of $46.5 million for the full year 2011.

Find out more about Delcath Systems including full access to the free equity report at: www.BedfordReport.com/DCTH

Western Refining, Inc. (NYSE: WNR) shares declined 4.16 percent on three times the average daily volume Wednesday to close at $31.14 a share. Refiners have fallen sharply in the past week on concerns that new standards proposed by the Environmental Protection Agency would pile on additional costs.

Find out more about Western Refining including full access to the free equity report at: www.BedfordReport.com/WNR

ExOne Co. (NASDAQ: XONE) shares have gained approximately 20 percent in the past month. The company reported record quarterly sales of 12.7 million for the fourth quarter of 2012, an increase of $10.0 million when compared to the fourth quarter of 2011. ExOne sold a total of 8 machines in the quarter.

Find out more about ExOne including full access to the free equity report at: www.BedfordReport.com/XONE

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.